Global Primary Cells Market Trends and Forecasts

1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Methodology Information Sources
1.5 Geographic Breakdown
1.6 Analyst's Credentials
1.7 Custom Research
1.8 Related Research Reports

3.1 Cell
3.2 Cell Culture
3.3 Cell Lines
3.4 Primary Cells
3.5 Primary Cells Vs. Cell Lines
3.6 Primary Cell Culture
3.6.1 Primary Cell Culture Media and Supplements
3.7 Characterization of Primary Cells
3.8 Primary Cell Culture Applications

4.1 Market Drivers
4.1.1 Increasing Incidence of Chronic Diseases
4.1.2 Demand for Effective Drug Discovery and Development Process
4.1.3 Minimizing Animal Testing
4.1.4 Advances in Primary Cells Culture Technologies
4.1.5 Growing Spending on Pharmaceutical R&D
4.1.6 Strong Biotech Funding
4.1.7 Growing Applications in 3D Cell Culture Models
4.1.8 Growing Focus on Personalized Medicine
4.1.9 Growing Demand in Cell Therapy Research
4.2 Market Restraints
4.2.1 Demanding Requirements of Primary Cells
4.2.2 Donor Tissue Supply Issues
4.2.3 Ethical and Regulatory Concerns
4.3 Market Trends
4.3.1 Growing Demand for Hla-Typed Human Primary Cells
4.3.2 Impact of Covid- 19

5.1 Introduction
5.1.1 Animal Primary Cells
5.1.2 Human Primary Cells
5.2 Global Market for Primary Cells by Biological Source

6.1 Primary Hematopoietic/Blood and Immune Cells
6.1.1 Overview
6.1.2 Hematopoietic Stem Cells (Hscs)
6.1.3 Applications
6.2 Primary Dermatocytes/Skin Cells
6.2.1 Overview
6.2.2 Applications
6.3 Gastrointestinal Cells
6.3.1 Overview
6.3.2 Applications
6.4 Primary Liver Cells/Hepatocytes
6.4.1 Overview
6.4.2 Applications
6.5 Primary Lung/Airway Cells
6.5.1 Overview
6.5.2 Applications
6.6 Renal/Kidney Cells
6.6.1 Overview
6.6.2 Applications
6.7 Primary Heart/Cardiac Cells
6.7.1 Overview
6.7.2 Applications
6.8 Musculoskeletal Cells
6.8.1 Overview
6.8.2 Applications
6.9 Other Primary Cells
6.9.1 Primary Brain Cells
6.9.2 Primary Brain Cells Applications
6.9.3 Other Primary Cells
6.10 Global Market for Primary Cells by Tissue Source Type
6.10.1 Primary Hematopoietic/Blood and Immune Cells
6.10.2 Primary Dermatocytes/Skin Cells
6.10.3 Primary Gastrointestinal Cells
6.10.4 Primary Liver Cells/Hepatocytes
6.10.5 Primary Lung/Airway Cells
6.10.6 Primary Renal/Kidney Cells
6.10.7 Primary Heart/Cardiac Cells
6.10.8 Primary Musculoskeletal Cells
6.10.9 Other Primary Cells

7.1 Overview
7.2 Global Market for Primary Cells by End-user Type
7.2.1 Life Science Research Companies
7.3 Academic and Other Research Institutes

8.1 Overview
8.2 Basic Research
8.3 Drug Discovery
8.4 Adme, Toxicology and Safety Assessment Studies
8.4.1 Adme and Toxicology Studies
8.4.2 Safety Assessment Studies
8.5 Cell Therapy Research
8.5.1 Basic Research
8.5.2 Drug Discovery
8.5.3 Cell Therapy Research

9.1 Global Market for Primary Cells by Region
9.2 North America
9.2.1 Market Revenue, by Tissue Source Type
9.2.2 Market Revenue, by Country
9.3 Europe
9.3.1 Market Revenue by Tissue Source Type
9.3.2 Market Revenue, by Country
9.4 Asia-Pacific
9.4.1 Market Revenue by Tissue Source Type
9.5 Rest of the World (Row)
9.5.1 Row Primary Cells Market by Tissue Source Type

10.1 Overview

Summary Table: Global Market for Primary Cells, by Biological Source Type, Through 2027
Table 1: Advantages and Disadvantages of Primary Cells
Table 2: Primary Cells vs. Cell Lines
Table 3: Clinical Trials Initiated Between 2015 and 2021, by Condition
Table 4: Biotech Funding (Capital Markets/IPOs/VCs), 2005-09 vs. 2020
Table 5: Global Market for Primary Cells, by Biological Source Type, Through 2027
Table 6: Relative Percentage of Each Immune Cell Type in Peripheral Blood Mononuclear Cells (PMBCs)
Table 7: Primary Cells by Tissue Source Type
Table 8: Global Market for Primary Cells, by Tissue Source Type, Through 2027
Table 9: NIH Funding for Neuroscience Research, by Year
Table 10: Global Market for Primary Cells, by End User Type, Through 2027
Table 11: Drug Discovery and Development Workflow
Table 12: Commonly Used Primary Cells for ADME, Toxicology, and Safety Assessment Studies
Table 13: Applications of Primary Cells in Drug Discovery and Development
Table 14: Stem Cell Uses in Research
Table 15: U.S. NIH Funding for Various Stem Cell Research (SCR) Areas, 2014-2023
Table 16: Global Market for Primary Cells, by Application Type, Through 2027
Table 17: Total Financing for Regenerative Medicine, by Therapeutic Area
Table 18: Global Market for Primary Cells, by Region, Through 2027
Table 19: North American Market for Primary Cells, by Tissue Source Type, Through 2027
Table 20: North American Primary Cells Market, by Country, Through 2027
Table 21: NIH Funding for Selected Research Categories, by Year
Table 22: European Market for Primary Cells, by Tissue Source Type, Through 2027
Table 23: European Primary Cells Market, by Country, Through 2027
Table 24: Number of Companies in the Life Sciences and Pharmaceutical Industry, with R&D Expenditure in Europe in 2019, by Country
Table 25: Asia-Pacific Market for Primary Cells, by Tissue Source Type, Through 2027
Table 26: Asia-Pacific Primary Cells Market, by Country, Through 2027
Table 27: Gross Domestic Spending on R&D, by Country, Through 2019
Table 28: RoW Market for Primary Cells, by Tissue Source Type, Through 2027
Table 29: Competitive Analysis of Primary Cell Manufacturers/Suppliers, 2021

Summary Figure: Global Market for Primary Cells, by Biological Source Type, 2019-2027
Figure 1: Basic Steps Used to Isolate Cells from Primary Tissue
Figure 2: Drug Development Process
Figure 3: Average R&D Intensities for Publicly Traded U.S. Companies, by Industry
Figure 4: Global Pharmaceutical R&D Spending, 2010-2019
Figure 5: Cellular Models Development Process
Figure 6: Personalized Medicines Contribution in Total FDA Approvals
Figure 7: Cell and Gene Therapy Pipeline, by Phase
Figure 8: Facts About Animals in Research
Figure 9: Global Market for Primary Cells, by Biological Source Type, 2019-2027
Figure 10: Global Market Shares of Primary Cells, by Biological Source Type, 2021
Figure 11: Blood Tissues and Isolated Cells
Figure 12: Hematopoiesis/Blood Cell Development
Figure 13: Functions of the Human Liver
Figure 14: Applications of Primary Hepatocytes in Drug Discovery and Development
Figure 15: Global Market for Primary Cells, by Tissue Source Type, 2019-2027
Figure 16: Global Market Shares of Primary Cells, by Tissue Source Type, 2021
Figure 17: Global Oncology Launches of Novel Active Substances, 2014-2021
Figure 18: Clinical Trials Started from 2016 to 2021, by Condition
Figure 19: Global Market for Primary Cells, by End User Type, 2019-2027
Figure 20: Global Market Shares of Primary Cells, by End User Type, 2021
Figure 21: Research Applications for Primary Cells
Figure 22: Primary Cells vs. Immortalized Cell Lines in Drug Discovery Research
Figure 23: Global Market for Primary Cells, by Application Type, 2019-2027
Figure 24: Global Market Shares of Primary Cells, by Application Type, 2021
Figure 25: Publications Referencing Cell Therapy, 2015-2021
Figure 26: Global Market for Primary Cells, by Region, 2019-2027
Figure 27: Global Market Shares of Primary Cells, by Region, 2021
Figure 28: Business Expenditures on Pharmaceutical R&D and Government Budgets for Health-related R&D, 2018 (or nearest year)
Figure 29: North American Market for Primary Cells, by Tissue Source Type, 2019-2027
Figure 30: North American Market Shares of Primary Cells, by Tissue Source Type, 2021
Figure 31: North American Primary Cells Market, by Country, 2019-2027
Figure 32: CIHR Fiscal Year Investments, by Primary Theme, 2017-2020
Figure 33: European Market for Primary Cells, by Tissue Source Type, 2019-2027
Figure 34: European Market Shares of Primary Cells, by Tissue Source Type, 2021
Figure 35: European Primary Cells Market, by Country, 2019-2027
Figure 36: European Countries’ Gross Domestic Spending on R&D, 2017-2019
Figure 37: Asia-Pacific Market for Primary Cells, by Tissue Source Type, 2019-2027
Figure 38: Asia-Pacific Market Shares of Primary Cells, by Tissue Source Type, 2021
Figure 39: Asia-Pacific Primary Cells Market, by Country, 2019-2027
Figure 40: RoW Market for Primary Cells, by Tissue Source Type, 2019-2027
Figure 41: RoW Market Shares of Primary Cells, by Tissue Source Type, 2021
Figure 42: Charles River Laboratories: Annual Revenue, 2019-2021
Figure 43: Charles River Laboratories: Revenue Share, by Region/Country, 2021
Figure 44: Charles River Laboratories’ RMS Business Segment: Annual Revenue, 2019-2021
Figure 45: Lonza: Annual Revenue, 2019-2021
Figure 46: Lonza: Revenue Share, by Region, 2021
Figure 47: Lonza’s Cell & Gene Division: Annual Revenue, 2019-2021
Figure 48: Merck KGaA’s Life Science Segment: Annual Revenue, 2019-2021
Figure 49: Merck KGaA’s Life Science Segment: Revenue Share, by Business Unit, 2021
Figure 50: Thermo Fisher Scientific: Annual Revenue, 2019-2021
Figure 51: Thermo Fisher Scientific: Revenue Share, by Region, 2021